Neurocrine Biosciences, Inc. (NASDAQ:NBIX)

CAPS Rating: 2 out of 5

Discovers, develops and intend to commercialize drugs for the treatment of neurological and endocrine-related diseases and disorders. Product candidates will target insomnia, anxiety, depression, cancer, diabetes, and multiple sclerosis.

Recs

0
Player Avatar HardnoseDotCom (73.45) Submitted: 4/25/2011 1:31:30 PM : Outperform Start Price: $7.65 NBIX Score: -13.91

low PEG, strong price uptrend

Featured Broker Partners


Advertisement